RSS Feeds
Search

Articles

Pharmalicensing brings you advice, commentary and analysis from industry experts.

Articles

No results found for given criteria.
Please try to put more general criteria into your selection.

Related Reports

Market Research Reports provided by reports.iptechex.com
Immune Network, Ltd. - Strategic SWOT Analysis Review
May 2011 - 15 pages - $250
Immune-tree International, Inc. (IMUT) - Strategic SWOT Analysis Review
May 2011 - 15 pages - $250
Company Financials: Genzyme Corporation
Jan 2010 - $75
AC Immune SA – Product Pipeline Review – Q4 2010
Dec 2010 - 37 pages - $500
Company Financials: Neurocrine Biosciences, Inc.
Jan 2010 - $75
Immunomodulators
Aug 2007 - 345 pages - $2,875
Primary Immune Deficiency (PID) - Pipeline Review, Q1 2011
Jan 2011 - 34 pages - $500
National Institute of Neurological Disorders and Stroke – Developmental Therapeutics Review – Q4 2010
Nov 2010 - 40 pages - $500
Lixte Biotechnology Holdings, Inc. (LIXT) - Strategic SWOT Analysis Review
Feb 2011 - 17 pages - $125
Lixte Biotechnology Holdings, Inc. - Strategic SWOT Analysis Review
Dec 2010 - 18 pages - $125
More Related Market Research Reports >>>

Your selection

Industry sector
Biotechnology del
Manufacturing del
Therapeutic target
Immune related disorders del
Myalgic encephalomyelitis del
Year
2001 del

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us